New warning for ddI.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D016049:Didanosine / Q000009:adverse effects*; D004347:Drug Interactions; D004348:Drug Labeling; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy; D006801:Humans; D012254:Ribavirin / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D012254:Ribavirin; D016049:Didanosine